These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3758472)

  • 1. Characterization of antiestrogen stimulation of cell number and prolactin production.
    Amara JF; Dannies PS
    Mol Cell Endocrinol; 1986 Oct; 47(3):183-9. PubMed ID: 3758472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures.
    Martinez-Campos A; Amara JF; Dannies PS
    Mol Cell Endocrinol; 1986 Dec; 48(2-3):127-33. PubMed ID: 3803705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
    Jordan VC; Gosden B
    Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.
    Black LJ; Goode RL
    Endocrinology; 1981 Sep; 109(3):987-9. PubMed ID: 7262030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and reversible inhibition of estradiol-stimulated prolactin synthesis by antiestrogens in vitro.
    Lieberman ME; Jordan VC; Fritsch M; Santos MA; Gorski J
    J Biol Chem; 1983 Apr; 258(8):4734-40. PubMed ID: 6833271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
    Jordan VC; Gosden B
    J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stimulation of uterine complement component C3 gene expression by antiestrogens.
    Sundstrom SA; Komm BS; Xu Q; Boundy V; Lyttle CR
    Endocrinology; 1990 Mar; 126(3):1449-56. PubMed ID: 2307112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular effects of antiestrogens (tamoxifen and LY117018) on estrogen-dependent glycoprotein (USP-1) synthesized and secreted by rat uterine epithelial cells.
    Takeda A; Shimizu S
    Endocrinology; 1988 Jul; 123(1):258-63. PubMed ID: 3383775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK; Boldt DH; Estrada P
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oestrogen and the antioestrogens, tamoxifen and LY117018, on four oestrogen-regulated RNAs in the EFM-19 breast cancer cell line.
    Westley BR; Hölzel F; May FE
    J Steroid Biochem; 1989 Mar; 32(3):365-72. PubMed ID: 2468045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tamoxifen on serum prolactin levels, pituitary immunoreactive prolactin cells and uterine growth in estradiol-treated ovariectomized rats.
    Spritzer PM; Ribeiro MF; Oliveira MC; Barbosa-Coutinho LM; Silva IS; Dahlem N; Cericatto R; Pavanato MA
    Horm Metab Res; 1996 Apr; 28(4):171-6. PubMed ID: 8740191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by tamoxifen of estrogen-stimulated accumulation of preprolactin messenger ribonucleic acid.
    Spona J; Leibl H
    Biochim Biophys Acta; 1981 Nov; 656(1):45-54. PubMed ID: 7306549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counteraction of estradiol-induced activation of tissue-type plasminogen activator in a human breast cancer cell line by an anti-estrogen, LY117018.
    Uchiumi T; Mizoguchi H; Hagino Y; Kohno K; Kuwano M
    Int J Cancer; 1991 Jan; 47(1):80-5. PubMed ID: 1702405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 17 beta-estradiol, synthetic estrogens, and antiestrogens on prolactin secretion, nuclear translocation of pituitary estrogen receptor and on progesterone receptor levels in rat pituitary, hypothalamus and uterus.
    Leibl H; Bieglmayer C; Spona J
    Endocrinol Exp; 1981; 15(1):35-44. PubMed ID: 6971219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparate effects of triphenylethylene antiestrogens on estrogen and progestin biosyntheses by cultured rat granulosa cells.
    Welsh TH; Jia XC; Jones PB; Zhuang LZ; Hsueh AJ
    Endocrinology; 1984 Oct; 115(4):1275-82. PubMed ID: 6434288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of prolactin production and cell growth by estradiol: difference in sensitivity to estradiol occurs at level of messenger ribonucleic acid accumulation.
    Amara JF; Van Itallie C; Dannies PS
    Endocrinology; 1987 Jan; 120(1):264-71. PubMed ID: 3780563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of estrogen- and antiestrogen-induced uterine complement component C3 expression by ICI 164,384.
    Galman MS; Sundstrom SA; Lyttle CR
    J Steroid Biochem; 1990 Jul; 36(4):281-6. PubMed ID: 2391957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure.
    Jordan VC; Lieberman ME
    Mol Pharmacol; 1984 Sep; 26(2):279-85. PubMed ID: 6541293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.